Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition.
about
Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and TherapyConcise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.Delivery of disulfiram into breast cancer cells using folate-receptor-targeted PLGA-PEG nanoparticles: in vitro and in vivo investigations.Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distribution.Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models.Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.A Comparative Cytotoxic Evaluation of Disulfiram Encapsulated PLGA Nanoparticles on MCF-7 Cells.Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer.Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4.Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts.The comparative effects of diethyldithiocarbamate-copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytesAnti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
P2860
Q26740191-F1E15394-1B17-44FF-B805-F82203C082AEQ35542866-F922BA43-01D4-44CC-B3A9-C845E0AE5C67Q36820304-94A8912F-DD0C-4C61-8595-ED996B5D2AA0Q37392908-596C06EC-AED5-4CF0-BE27-F8849AAA9CCDQ37696104-34535B65-C987-4362-8A03-A3237EE08ED9Q41082509-3C1602E1-1327-45B3-9B82-BA373C57BC2DQ41553505-52AB429F-0BDE-4785-BF76-C334FDB75872Q41887816-2E947622-0D8C-481A-A565-82D1666FB8ACQ46185130-01A4DDCA-A16C-4BFC-921B-E132BA92BEC4Q49181990-6565FDE0-6672-4392-9CD6-011EE5108222Q51642518-C809E238-12E6-4F74-9CE0-7F7F1A3E1EE6Q58744474-F93C50A7-B8A9-4791-9AD3-2F81BAA1F52F
P2860
Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@ast
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@en
type
label
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@ast
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@en
prefLabel
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@ast
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@en
P2093
P2860
P356
P1476
Disulfiram targeting lymphoid ...... and NF-kB pathway inhibition.
@en
P2093
Feili Chen
Huijuan Dong
Pengcheng Shi
Rongwei Li
Shiyun Wang
Weiguang Wang
Yanyan Zhang
P2860
P2888
P356
10.1186/1479-5876-12-163
P577
2014-06-11T00:00:00Z
P5875
P6179
1040366412